​

​

Plant-Derived Pharmaceutical Innovation

Modern medicine has benefited from medicines discovered through synthetic chemistry, biotechnology, and natural products. Many important pharmaceuticals—including aspirin, artemisinin, paclitaxel, quinine, and morphine—originate from plants or were inspired by naturally occurring compounds.

​

At Stramsen Biotech, we harness this rich biological diversity to discover and develop plant-derived therapeutic assets using modern pharmaceutical science. By integrating traditional medicinal knowledge with phytochemistry, pharmacology, toxicology, regulatory science, and clinical development, we transform promising natural compounds into rigorously evaluated pharmaceutical products.

​

The growing challenge of antimicrobial resistance (AMR), together with the need for new therapies across many disease areas, underscores the importance of expanding the sources of pharmaceutical innovation. Through our diversified pipeline, Stramsen is advancing the next generation of plant-derived medicines to address significant unmet medical needs worldwide.

 

​